百洋医药(301015.SZ)：前三季度净利润4.76亿元 同比减少25.67%

Core Viewpoint - Baiyang Pharmaceutical (301015.SZ) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the same period last year [1] Financial Performance - The company achieved operating revenue of 5.627 billion yuan, a year-on-year decrease of 8.41% [1] - The net profit attributable to shareholders was 476 million yuan, down 25.67% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 410 million yuan, a decrease of 32.87% year-on-year [1] - Basic earnings per share stood at 0.91 yuan [1]